/
/
/

Ipca Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018
₹2788 Cr₹2388 Cr₹2393 Cr₹2557 Cr₹2309 Cr₹2247 Cr₹2245 Cr₹2355 Cr₹2093 Cr₹2033 Cr₹2053 Cr₹2034 Cr₹1585 Cr₹1512 Cr₹1546 Cr₹1601 Cr₹1586 Cr₹1289 Cr₹1430 Cr₹1544 Cr₹1566 Cr₹1115 Cr₹1410 Cr₹1361 Cr₹1534 Cr₹1074 Cr₹1213 Cr₹1284 Cr₹1078 Cr₹880 Cr₹1006 Cr₹1012 Cr₹875 Cr
₹25 Cr₹94 Cr₹20 Cr₹28 Cr₹33 Cr₹26 Cr₹20 Cr₹26 Cr₹21 Cr₹19 Cr₹22 Cr₹39 Cr₹45 Cr₹36 Cr₹31 Cr₹36 Cr₹22 Cr₹15 Cr₹13 Cr₹18 Cr₹21 Cr₹20 Cr₹15 Cr₹15 Cr₹12 Cr₹14 Cr₹18 Cr₹15 Cr₹20 Cr₹15 Cr₹13 Cr₹15 Cr₹14 Cr
₹2813 Cr₹2482 Cr₹2413 Cr₹2584 Cr₹2342 Cr₹2273 Cr₹2265 Cr₹2381 Cr₹2113 Cr₹2052 Cr₹2075 Cr₹2073 Cr₹1630 Cr₹1548 Cr₹1577 Cr₹1637 Cr₹1608 Cr₹1304 Cr₹1443 Cr₹1563 Cr₹1587 Cr₹1135 Cr₹1425 Cr₹1377 Cr₹1546 Cr₹1087 Cr₹1231 Cr₹1299 Cr₹1099 Cr₹895 Cr₹1019 Cr₹1027 Cr₹890 Cr
₹2229 Cr₹2012 Cr₹1967 Cr₹2115 Cr₹1992 Cr₹1918 Cr₹1881 Cr₹2014 Cr₹1799 Cr₹1809 Cr₹1821 Cr₹1764 Cr₹1347 Cr₹1400 Cr₹1397 Cr₹1404 Cr₹1378 Cr₹1131 Cr₹1181 Cr₹1236 Cr₹1205 Cr₹938 Cr₹1096 Cr₹1053 Cr₹997 Cr₹969 Cr₹990 Cr₹1068 Cr₹926 Cr₹760 Cr₹817 Cr₹883 Cr₹803 Cr
₹695 Cr₹578 Cr₹554 Cr₹573 Cr₹449 Cr₹455 Cr₹483 Cr₹468 Cr₹413 Cr₹341 Cr₹353 Cr₹399 Cr₹353 Cr₹217 Cr₹247 Cr₹297 Cr₹291 Cr₹234 Cr₹321 Cr₹384 Cr₹438 Cr₹249 Cr₹382 Cr₹376 Cr₹600 Cr₹182 Cr₹292 Cr₹281 Cr₹219 Cr₹180 Cr₹248 Cr₹189 Cr₹133 Cr
₹12 Cr₹20 Cr₹18 Cr₹20 Cr₹19 Cr₹22 Cr₹17 Cr₹23 Cr₹24 Cr₹29 Cr₹33 Cr₹44 Cr₹31 Cr₹18 Cr₹11 Cr₹9 Cr₹7 Cr₹3 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹6 Cr₹5 Cr₹2 Cr₹5 Cr
₹572 Cr₹404 Cr₹446 Cr₹392 Cr₹331 Cr₹128 Cr₹368 Cr₹345 Cr₹290 Cr₹77 Cr₹289 Cr₹225 Cr₹252 Cr₹129 Cr₹169 Cr₹224 Cr₹223 Cr₹170 Cr₹261 Cr₹326 Cr₹380 Cr₹195 Cr₹327 Cr₹321 Cr₹547 Cr₹115 Cr₹237 Cr₹227 Cr₹168 Cr₹129 Cr₹197 Cr₹141 Cr₹81 Cr
₹423 Cr₹309 Cr₹364 Cr₹284 Cr₹234 Cr₹66 Cr₹277 Cr₹245 Cr₹199 Cr₹3 Cr₹223 Cr₹137 Cr₹166 Cr₹81 Cr₹116 Cr₹147 Cr₹148 Cr₹141 Cr₹203 Cr₹258 Cr₹309 Cr₹164 Cr₹270 Cr₹269 Cr₹447 Cr₹85 Cr₹200 Cr₹195 Cr₹131 Cr₹97 Cr₹160 Cr₹119 Cr₹68 Cr

Share Price Live Stats

Open (₹)1,950.00
Volume (₹)33,153.00
High (₹)1,967.60
Upper Circuit2,347.30
Low (₹)1,944.20
Lower Circuit1,564.90
Prev Close1,956.10
52W High (₹)2,001.50
Price1,961.50
52W Low (₹)1,251.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)49604.20 Cr
Div. Yield (%)0.31
PE Ratio37.87
Debt to Equity0.09
Price to Book5.05
Book Value317.72
EPS (TTM)51.63
Face Value1.00
ROE (%)15.88

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
IPCALABNSE
LTP
1W Low
1W High
Market cap (₹)
1904.6-15.4 (-0.80%)
1902
1984.80
4,56,833Cr
9188.5-50.5 (-0.55%)
9087
9467
2,45,426Cr
4887-163 (-3.23%)
4886.50
5066
1,87,320Cr
1132.4-58.6 (-4.92%)
1125.10
1187
1,13,217Cr
1389.8-33.7 (-2.37%)
1376.70
1426.10
1,12,212Cr
1853.5-85 (-4.38%)
1811.70
1949
1,01,155Cr
2124.8-46.7 (-2.15%)
2118.10
2192
97,626Cr
2350.9-32 (-1.34%)
2341.20
2419.20
96,859Cr
1163.8-14.2 (-1.21%)
1154.40
1179.90
96,406Cr
1655+9.7 (0.59%)
1622.60
1717
93,614Cr
1961.5+11.2 (0.57%)
1907.90
2001.50
49,604Cr

Key Highlights of Ipca Laboratories Ltd’s P&L

In 2026-03-31, Ipca Laboratories Ltd reported total revenue of ₹9800.71Cr, compared with ₹9048.13Cr in 2025-03-31, reflecting Ipca Laboratories Ltd turnover.

Depreciation was ₹418.12Cr and finance costs were ₹79.09Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹1572.52Cr in 2026-03-31 as compared to ₹1131.14Cr in 2025-03-31.

Net Profit (PAT) was ₹1141.12Cr in 2026-03-31 compared with ₹737.68Cr in 2025-03-31.

Earnings per share (EPS) were ₹44.98 in 2026-03-31, compared with ₹29.08 in 2025-03-31.